Daniel Billen
Chairman at AURINIA PHARMACEUTICALS INC.
Net worth: 162 624 $ as of 2024-04-29
Profile
Daniel G.
Billen's current job is Chairman at Aurinia Pharmaceuticals, Inc. His former jobs include Vice President & General Manager at Amgen, Inc., General Manager at Amgen Canada, Inc., and Head-Marketing & Sales at Janssen, Inc. He holds a doctorate degree from Université Catholique de Louvain.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2023-05-22 | 33,393 ( 0.02% ) | 162 624 $ | 2024-04-29 |
Daniel Billen active positions
Companies | Position | Start |
---|---|---|
AURINIA PHARMACEUTICALS INC. | Chairman | 2023-08-17 |
Former positions of Daniel Billen
Companies | Position | End |
---|---|---|
AMGEN INC. | Corporate Officer/Principal | 2017-12-31 |
Amgen Canada, Inc.
Amgen Canada, Inc. BiotechnologyHealth Technology Amgen Canada, Inc. operates as a biotechnology company. The company was founded in 1991 and is headquartered in Mississauga, Canada. | Corporate Officer/Principal | 2010-12-31 |
Janssen, Inc.
Janssen, Inc. Pharmaceuticals: MajorHealth Technology Janssen, Inc. operates as a pharmaceutical company of Johnson & Johnson. Its products include Caelyx, Concerta, Cyclen, Ditropan XL, Duragesic, Edurant, Evra, Galexos, Invega, Invokana, Jurnista, Livostin, Pariet, Remicade, Sylvant, Topamax, Ultram, Velcade, Yondelis, and Zytiga. The company is headquartered in Toronto, Canada. | Sales & Marketing | 1990-12-31 |
Training of Daniel Billen
Université Catholique de Louvain | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
AMGEN INC. | Health Technology |
AURINIA PHARMACEUTICALS INC. | Health Technology |
Private companies | 2 |
---|---|
Amgen Canada, Inc.
Amgen Canada, Inc. BiotechnologyHealth Technology Amgen Canada, Inc. operates as a biotechnology company. The company was founded in 1991 and is headquartered in Mississauga, Canada. | Health Technology |
Janssen, Inc.
Janssen, Inc. Pharmaceuticals: MajorHealth Technology Janssen, Inc. operates as a pharmaceutical company of Johnson & Johnson. Its products include Caelyx, Concerta, Cyclen, Ditropan XL, Duragesic, Edurant, Evra, Galexos, Invega, Invokana, Jurnista, Livostin, Pariet, Remicade, Sylvant, Topamax, Ultram, Velcade, Yondelis, and Zytiga. The company is headquartered in Toronto, Canada. | Health Technology |
- Stock Market
- Insiders
- Daniel Billen